Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
Immuneering Corporation Reports Q1 2026 Financial Results
2026-05-15
SEC Filing 10-Q
(0001790340-26-000057)
Please check the link below for details.
Ticker mentioned:
IMRX
Source:
Original SEC Document β